{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:25Z","timestamp":1793299105394,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PrionDiff","award":["Project-ANR-21-CE15-0011"],"award-info":[{"award-number":["Project-ANR-21-CE15-0011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11538-025-01553-8","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T02:50:26Z","timestamp":1762051826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Modelling of anti-inflammatory treatment in the Alzheimer disease: optimal regimen and outcome"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8384-4916","authenticated-orcid":false,"given":"Wissam","family":"El Hajj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pujo-Menjouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9on Matar","family":"Tine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Volpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,2]]},"reference":[{"key":"1553_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2019 Dementia Forecasting Collaborators, (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public health 7(2):e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","DOI":"10.1016\/S2468-2667(21)00249-8"},{"issue":"24","key":"1553_CR2","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TP (2013) Proliferation of amyloid-$$\\beta $$42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA 110(24):9758\u20139763. https:\/\/doi.org\/10.1073\/pnas.1218402110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1553_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","volume":"277","author":"M Sakono","year":"2010","unstructured":"Sakono M, Zako T (2010) Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277(6):1348\u20131358. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07568.x","journal-title":"FEBS J"},{"key":"1553_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R (2016) The Role of Amyloid-$$\\beta $$ Oligomers in Toxicity, Propagation, and Immunotherapy. EBioMedicine 6:42\u201349. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.035","journal-title":"EBioMedicine"},{"issue":"2","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5607\/en22004","volume":"31","author":"H Jeong","year":"2022","unstructured":"Jeong H, Shin H, Hong S, Kim Y (2022) Physiological Roles of Monomeric Amyloid-$$\\beta $$ and Implications for Alzheimer\u2019s Disease Therapeutics. Experimental neurobiology 31(2):65\u201388. https:\/\/doi.org\/10.5607\/en22004","journal-title":"Experimental neurobiology"},{"issue":"16","key":"1553_CR6","doi-asserted-by":"publisher","first-page":"13827","DOI":"10.1074\/jbc.M110.199885","volume":"286","author":"S Nag","year":"2011","unstructured":"Nag S, Sarkar B, Bandyopadhyay A, Sahoo B, Sreenivasan VK, Kombrabail M, Muralidharan C, Maiti S (2011) Nature of the amyloid-beta monomer and the monomer-oligomer equilibrium. J Biol Chem 286(16):13827\u201313833. https:\/\/doi.org\/10.1074\/jbc.M110.199885","journal-title":"J Biol Chem"},{"issue":"5","key":"1553_CR7","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101(5):1172\u20131184. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04426.x","journal-title":"J Neurochem"},{"issue":"7","key":"1553_CR8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/molecules25071659","volume":"25","author":"B Penke","year":"2020","unstructured":"Penke B, Sz\u0171cs M, Bog\u00e1r F (2020) Oligomerization and Conformational Change Turn Monomeric $$\\beta $$-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer\u2019s Pathogenesis. Molecules (Basel Switzerland) 25(7):1659. https:\/\/doi.org\/10.3390\/molecules25071659","journal-title":"Molecules (Basel Switzerland)"},{"issue":"6","key":"1553_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jb\/mvae023","volume":"175","author":"T Kaku","year":"2024","unstructured":"Kaku T, Ikebukuro K, Tsukakoshi K (2024) Structure of cytotoxic amyloid oligomers generated during disaggregation. The Journal of Biochemistry 175(6):575\u2013585. https:\/\/doi.org\/10.1093\/jb\/mvae023","journal-title":"The Journal of Biochemistry"},{"issue":"10","key":"1553_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-v","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12(10):383\u2013388. https:\/\/doi.org\/10.1016\/0165-6147(91)90609-v","journal-title":"Trends Pharmacol Sci"},{"key":"1553_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"IC Hoogland","year":"2015","unstructured":"Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D (2015) Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation 12:114. https:\/\/doi.org\/10.1186\/s12974-015-0332-6","journal-title":"J Neuroinflammation"},{"key":"1553_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100149","volume":"4","author":"V Rani","year":"2022","unstructured":"Rani V, Verma R, Kumar K, Chawla R (2022) Role of pro-inflammatory cytokines in Alzheimer\u2019s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds. Current research in pharmacology and drug discovery 4:100149. https:\/\/doi.org\/10.1016\/j.crphar.2022.100149","journal-title":"Current research in pharmacology and drug discovery"},{"issue":"3","key":"1553_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11481-016-9668-7","volume":"11","author":"V Douet","year":"2016","unstructured":"Douet V, Tanizaki N, Franke A, Li X, Chang L (2016) Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV. Journal of neuroimmune pharmacology the official journal of the Society on NeuroImmune Pharmacology 11(3):549\u2013561. https:\/\/doi.org\/10.1007\/s11481-016-9668-7","journal-title":"Journal of neuroimmune pharmacology the official journal of the Society on NeuroImmune Pharmacology"},{"issue":"6","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00281-015-0515-3","volume":"37","author":"V Rothhammer","year":"2015","unstructured":"Rothhammer V, Quintana FJ (2015) Control of autoimmune CNS inflammation by astrocytes. Seminars in immunopathology 37(6):625\u2013638. https:\/\/doi.org\/10.1007\/s00281-015-0515-3","journal-title":"Seminars in immunopathology"},{"key":"1553_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y (2022) Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Frontiers in aging neuroscience 14:815347. https:\/\/doi.org\/10.3389\/fnagi.2022.815347","journal-title":"Frontiers in aging neuroscience"},{"issue":"2","key":"1553_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W (2016) Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol 53(2):1181\u20131194. https:\/\/doi.org\/10.1007\/s12035-014-9070-5","journal-title":"Mol Neurobiol"},{"issue":"5","key":"1553_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12264-016-0055-4","volume":"32","author":"F Su","year":"2016","unstructured":"Su F, Bai F, Zhang Z (2016) Inflammatory Cytokines and Alzheimer\u2019s Disease: A Review from the Perspective of Genetic Polymorphisms. Neurosci Bull 32(5):469\u2013480. https:\/\/doi.org\/10.1007\/s12264-016-0055-4","journal-title":"Neurosci Bull"},{"key":"1553_CR18","doi-asserted-by":"publisher","unstructured":"Taipa R, dasNeves SP, Sousa AL, Fernandes J, Pinto C, Correia AP, Santos E, Pinto PS, Carneiro P, Costa P, Santos D, Alonso I, Palha J, Marques F, Cavaco S, Sousa N (2019) Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline. Neurobiol Aging 76:125\u2013132. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.019","DOI":"10.1016\/j.neurobiolaging.2018.12.019"},{"issue":"6","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","volume":"173","author":"MC Janelsins","year":"2008","unstructured":"Janelsins MC, Mastrangelo MA, Park KM, Sudol KL, Narrow WC, Oddo S, LaFerla FM, Callahan LM, Federoff HJ, Bowers WJ (2008) Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am J Pathol 173(6):1768\u20131782. https:\/\/doi.org\/10.2353\/ajpath.2008.080528","journal-title":"Am J Pathol"},{"issue":"2","key":"1553_CR20","first-page":"25","volume":"8","author":"E Tobinick","year":"2006","unstructured":"Tobinick E, Gross H, Weinberger A, Cohen H (2006) TNF-alpha modulation for treatment of Alzheimer\u2019s disease: a 6-month pilot study. MedGenMed Medscape general medicine 8(2):25","journal-title":"MedGenMed Medscape general medicine"},{"key":"1553_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.01.049","volume":"207","author":"K Kawahara","year":"2012","unstructured":"Kawahara K, Suenobu M, Yoshida A, Koga K, Hyodo A, Ohtsuka H, Kuniyasu A, Tamamaki N, Sugimoto Y, Nakayama H (2012) Intracerebral microinjection of interleukin-4\/interleukin-13 reduces $$\\beta $$-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 207:243\u2013260. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.01.049","journal-title":"Neuroscience"},{"key":"1553_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnagi.2010.00020","volume":"2","author":"M Sastre","year":"2010","unstructured":"Sastre M, Gentleman SM (2010) NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer\u2019s Disease. Frontiers in aging neuroscience 2:20. https:\/\/doi.org\/10.3389\/fnagi.2010.00020","journal-title":"Frontiers in aging neuroscience"},{"issue":"6","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3390\/ph3061949","volume":"3","author":"MA Ajmone-Cat","year":"2010","unstructured":"Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L (2010) Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions. Pharmaceuticals (Basel Switzerland) 3(6):1949\u20131965. https:\/\/doi.org\/10.3390\/ph3061949","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"1553_CR24","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/756357","volume":"2012","author":"JM Rubio-Perez","year":"2012","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines. TheScientificWorldJOURNAL 2012:756357. https:\/\/doi.org\/10.1100\/2012\/756357","journal-title":"TheScientificWorldJOURNAL"},{"issue":"2","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"fcaa109","DOI":"10.1093\/braincomms\/fcaa109","volume":"2","author":"J Rivers-Auty","year":"2020","unstructured":"Rivers-Auty J, Mather AE, Peters R, Lawrence CB, Brough D (2020) Anti-inflammatories in Alzheimer\u2019s disease-potential therapy or spurious correlate? Brain commun. 2(2):fcaa109. https:\/\/doi.org\/10.1093\/braincomms\/fcaa109","journal-title":"Brain commun."},{"issue":"s1","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.3233\/JAD-179913","volume":"64","author":"PL McGeer","year":"2018","unstructured":"McGeer PL, McGeer E (2018) Conquering Alzheimer\u2019s Disease by Self Treatment. Journal of Alzheimer\u2019s disease JAD 64(s1):S361\u2013S363. https:\/\/doi.org\/10.3233\/JAD-179913","journal-title":"Journal of Alzheimer\u2019s disease JAD"},{"issue":"5","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11095-006-9905-5","volume":"23","author":"JM Parepally","year":"2006","unstructured":"Parepally JM, Mandula H, Smith QR (2006) Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm Res 23(5):873\u2013881. https:\/\/doi.org\/10.1007\/s11095-006-9905-5","journal-title":"Pharm Res"},{"issue":"34","key":"1553_CR28","doi-asserted-by":"publisher","first-page":"31825","DOI":"10.1074\/jbc.M303588200","volume":"278","author":"SA Sagi","year":"2003","unstructured":"Sagi SA, Weggen S, Eriksen J, Golde TE, Koo EH (2003) The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production. J Biol Chem 278(34):31825\u201331830. https:\/\/doi.org\/10.1074\/jbc.M303588200","journal-title":"J Biol Chem"},{"issue":"11","key":"1553_CR29","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00018-007-6516-1","volume":"64","author":"A Lleo","year":"2007","unstructured":"Lleo A, Galea E, Sastre M (2007) Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cellular and molecular life sciences CMLS 64(11):1403\u20131418. https:\/\/doi.org\/10.1007\/s00018-007-6516-1","journal-title":"Cellular and molecular life sciences CMLS"},{"issue":"2","key":"1553_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40266-015-0239-z","volume":"32","author":"M Miguel-\u00c1lvarez","year":"2015","unstructured":"Miguel-\u00c1lvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, Lucia A (2015) Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis of treatment effect. Drugs & aging 32(2):139\u2013147. https:\/\/doi.org\/10.1007\/s40266-015-0239-z","journal-title":"Drugs & aging"},{"issue":"3","key":"1553_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/wnl.48.3.626","volume":"48","author":"WF Stewart","year":"1997","unstructured":"Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer\u2019s disease and duration of NSAID use. Neurology 48(3):626\u2013632. https:\/\/doi.org\/10.1212\/wnl.48.3.626","journal-title":"Neurology"},{"issue":"2","key":"1553_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/imammb\/dqw003","volume":"34","author":"M Bertsch","year":"2017","unstructured":"Bertsch M, Franchi B, Marcello N, Tesi MC, Tosin A (2017) Alzheimer\u2019s disease: a mathematical model for onset and progression. Mathematical medicine and biology a journal of the IMA 34(2):193\u2013214. https:\/\/doi.org\/10.1093\/imammb\/dqw003","journal-title":"Mathematical medicine and biology a journal of the IMA"},{"issue":"5","key":"1553_CR33","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00285-013-0732-0","volume":"69","author":"M Helal","year":"2014","unstructured":"Helal M, Hingant E, Pujo-Menjouet L, Webb GF (2014) Alzheimer\u2019s disease: analysis of a mathematical model incorporating the role of prions. J Math Biol 69(5):1207\u20131235. https:\/\/doi.org\/10.1007\/s00285-013-0732-0","journal-title":"J Math Biol"},{"key":"1553_CR34","doi-asserted-by":"publisher","unstructured":"Andrade-Restrepo M, Lemarre P, Pujo-Menjouet L, Tine L, Ciuperca S (2020). Modeling the spatial propagation of A$$\\beta $$ oligomers in Alzheimer\u2019s Disease. ESAIM: Proceedings and Surveys, 67, 30\u201345. https:\/\/doi.org\/10.1051\/proc\/202067003.","DOI":"10.1051\/proc\/202067003."},{"key":"1553_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brain.2020.100020","volume":"2","author":"M Bertsch","year":"2021","unstructured":"Bertsch M, Franchi B, Meschini V, Tesi MC, Tosin A (2021) A sensitivity analysis of a mathematical model for the synergistic interplay of amyloid beta and tau on the dynamics of Alzheimer\u2019s disease. Brain Multiphysics 2:100020. https:\/\/doi.org\/10.1016\/j.brain.2020.100020","journal-title":"Brain Multiphysics"},{"issue":"12","key":"1553_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015176","volume":"5","author":"IK Puri","year":"2010","unstructured":"Puri IK, Li L (2010) Mathematical modeling for the pathogenesis of Alzheimer\u2019s disease. PLoS ONE 5(12):e15176. https:\/\/doi.org\/10.1371\/journal.pone.0015176","journal-title":"PLoS ONE"},{"issue":"5","key":"1553_CR37","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.231536","volume":"11","author":"I Ciuperca","year":"2024","unstructured":"Ciuperca I, Pujo-Menjouet L, Matar-Tine L, Torres N, Volpert V (2024) A qualitative analysis of an A$$\\beta $$-monomer model with inflammation processes for Alzheimer\u2019s disease. Royal Society open science 11(5):231536. https:\/\/doi.org\/10.1098\/rsos.231536","journal-title":"Royal Society open science"},{"issue":"4","key":"1553_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299637","volume":"19","author":"C Lee","year":"2024","unstructured":"Lee C, Friedman A (2024) Generating PET scan patterns in Alzheimer\u2019s by a mathematical model. PLoS ONE 19(4):e0299637. https:\/\/doi.org\/10.1371\/journal.pone.0299637","journal-title":"PLoS ONE"},{"issue":"1","key":"1553_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12918-016-0348-2","volume":"10","author":"W Hao","year":"2016","unstructured":"Hao W, Friedman A (2016) Mathematical model on Alzheimer\u2019s disease. BMC Syst Biol 10(1):108. https:\/\/doi.org\/10.1186\/s12918-016-0348-2","journal-title":"BMC Syst Biol"},{"key":"1553_CR40","unstructured":"Haraux A (2016 ) A simple characterization of positivity preserving semi-linear parabolic systems. (doi:https:\/\/arxiv.org\/abs\/1610.09909)"},{"key":"1553_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/jpr.s6993","volume":"3","author":"PB Bookstaver","year":"2010","unstructured":"Bookstaver PB, Miller AD, Rudisill CN, Norris LB (2010) Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. J Pain Res 3:67\u201379. https:\/\/doi.org\/10.2147\/jpr.s6993","journal-title":"J Pain Res"},{"issue":"20","key":"1553_CR42","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.110.004671","volume":"123","author":"AM Schjerning Olsen","year":"2011","unstructured":"Schjerning Olsen AM, Fosb\u00f8l EL, Lindhardsen J, Folke F, Charlot M, Selmer C, Lamberts M, Bjerring Olesen J, K\u00f8ber L, Hansen PR, Torp-Pedersen C, Gislason GH (2011) Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation 123(20):2226\u20132235. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.004671","journal-title":"Circulation"},{"issue":"3","key":"1553_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.chembiol.2017.02.003","volume":"24","author":"CE Smith","year":"2017","unstructured":"Smith CE, Soti S, Jones TA, Nakagawa A, Xue D, Yin H (2017) Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors. Cell Chem Biol 24(3):281\u2013292. https:\/\/doi.org\/10.1016\/j.chembiol.2017.02.003","journal-title":"Cell Chem Biol"},{"issue":"1","key":"1553_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5701","volume":"33","author":"TL Kelly","year":"2024","unstructured":"Kelly TL, Salter A, Pratt NL (2024) The weighted cumulative exposure method and its application to pharmacoepidemiology: A narrative review. Pharmacoepidemiol Drug Saf 33(1):e5701. https:\/\/doi.org\/10.1002\/pds.5701","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1553_CR45","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-170706","volume":"62","author":"PL McGeer","year":"2018","unstructured":"McGeer PL, Guo JP, Lee M, Kennedy K, McGeer EG (2018) Alzheimer\u2019s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs. J Alzheimers Dis 62:1219\u20131222. https:\/\/doi.org\/10.3233\/JAD-170706","journal-title":"J Alzheimers Dis"},{"key":"1553_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnagi.2010.00019","volume":"2","author":"BP Imbimbo","year":"2010","unstructured":"Imbimbo BP, Solfrizzi V, Panza F (2010) Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment? Frontiers in aging neuroscience 2:19. https:\/\/doi.org\/10.3389\/fnagi.2010.00019","journal-title":"Frontiers in aging neuroscience"},{"key":"1553_CR47","doi-asserted-by":"publisher","unstructured":"Green R C, Schneider L S, Amato D A, Beelen A P, Wilcock G, Swabb E A, Zavitz K H, Tarenflurbil Phase 3 Study Group (2009) Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 302(23):2557\u20132564. https:\/\/doi.org\/10.1001\/jama.2009.1866","DOI":"10.1001\/jama.2009.1866"},{"issue":"3","key":"1553_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10552-011-9891-8","volume":"23","author":"TM Brasky","year":"2012","unstructured":"Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E (2012) Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer causes & control CCC 23(3):431\u2013444. https:\/\/doi.org\/10.1007\/s10552-011-9891-8","journal-title":"Cancer causes & control CCC"},{"issue":"4","key":"1553_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/94.4.252\/","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94(4):252\u2013266. https:\/\/doi.org\/10.1093\/jnci\/94.4.252\/","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1553_CR50","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1111\/bcp.14032","volume":"85","author":"HG Stampfer","year":"2019","unstructured":"Stampfer HG, Gabb GM, Dimmitt SB (2019) Why maximum tolerated dose? Br J Clin Pharmacol 85(10):2213\u20132217. https:\/\/doi.org\/10.1111\/bcp.14032","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1553_CR51","first-page":"319","volume":"2","author":"RD Brook","year":"2000","unstructured":"Brook RD, Kramer MB, Blaxall BC, Bisognano JD (2000) Nonsteroidal Anti-Inflammatory Drugs and Hypertension. J. Clin. Hypertens.(Greenwich, Conn.) 2(5):319\u2013323","journal-title":"J. Clin. Hypertens.(Greenwich, Conn.)"},{"issue":"4","key":"1553_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.817","volume":"9","author":"S Dro\u017cd\u017cal","year":"2021","unstructured":"Dro\u017cd\u017cal S, Lechowicz K, Szostak B, Rosik J, Kotfis K, Machoy-Mokrzy\u0144ska A, Bia\u0142ecka M, Ciechanowski K, Gawro\u0144ska-Szklarz B (2021) Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature. Pharmacology research & perspectives 9(4):e00817. https:\/\/doi.org\/10.1002\/prp2.817","journal-title":"Pharmacology research & perspectives"},{"issue":"6","key":"1553_CR53","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.3934\/mbe.2021419","volume":"18","author":"Z Xiong","year":"2021","unstructured":"Xiong Z, Li X, Ye M, Zhang Q (2021) Finite-time stability and optimal control of an impulsive stochastic reaction-diffusion vegetation-water system driven by L\u00e9vy process with time-varying delay. Mathematical biosciences and engineering MBE 18(6):8462\u20138498. https:\/\/doi.org\/10.3934\/mbe.2021419","journal-title":"Mathematical biosciences and engineering MBE"},{"issue":"4","key":"1553_CR54","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3233\/JAD-230418","volume":"96","author":"WB Grant","year":"2023","unstructured":"Grant WB, Blake SM (2023) Diet\u2019s Role in Modifying Risk of Alzheimer\u2019s Disease: History and Present Understanding. Journal of Alzheimer\u2019s disease JAD 96(4):1353\u20131382. https:\/\/doi.org\/10.3233\/JAD-230418","journal-title":"Journal of Alzheimer\u2019s disease JAD"},{"issue":"12","key":"1553_CR55","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.1002\/alz.14313","volume":"20","author":"W Wang","year":"2024","unstructured":"Wang W, Wang Q, Qi X, Gurney M, Perry G, Volkow ND, Davis PB, Kaelber DC, Xu R (2024) Associations of semaglutide with first-time diagnosis of Alzheimer\u2019s disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimer\u2019s & dementia the journal of the Alzheimer\u2019s Association 20(12):8661\u20138672. https:\/\/doi.org\/10.1002\/alz.14313","journal-title":"Alzheimer\u2019s & dementia the journal of the Alzheimer\u2019s Association"},{"issue":"1","key":"1553_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","volume":"36","author":"CK Wong","year":"2024","unstructured":"Wong CK, McLean BA, Baggio LL, Koehler JA, Hammoud R, Rittig N, Yabut JM, Seeley RJ, Brown TJ, Drucker DJ (2024) Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Cell Metab 36(1):130-143.e5. https:\/\/doi.org\/10.1016\/j.cmet.2023.11.009","journal-title":"Cell Metab"}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-025-01553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-025-01553-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-025-01553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T03:44:34Z","timestamp":1765943074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-025-01553-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,2]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s11538-025-01553-8","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,2]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work does not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"171"}}